Immunomonitoring Service Platform (ISP) |
Singapore Immunology Network (SIgN) hosts a state-of-the-art Immunomonitoring (IM) platform with an integrated suite of capabilities including: |
|
With applications in immune profiling, biomarker discovery, target identification, vaccine assessment, patient treatment stratification and clinical trial monitoring, the SIgN IM platform has more than 130 successful partnerships and over 1,164 scientific publications since 2007 (as of 2019). |
Key Capabilities |
Largest flow cytometry platform in South East Asia |
|
Scope of Services |
|
Samples |
|
Applications (non-exhaustive) |
|
Sensitive detection of cytokines, chemokines & metabolites |
|
Exploratory panel kits (Immune-related research) |
|
Scope of Services |
|
Samples |
|
Applications (non-exhaustive) |
|
Integration of hetergeneous data sets to accelerate research |
|
Scope of Services |
|
Applications (non-exhaustive) |
1. Analysis of NGS data which may include:
|
2. Analysis of hetergeneous data including:
|